# OnCo record grit-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/grit-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "grit-bio" ;
  schema:name "Grit Bio"@en ;
  schema:alternateName "Grit Biotechnology"@en, "GRIT Biotherapeutics"@en, "沙砾生物"@en ;
  schema:description "Grit Bio is a China-based cell therapy company that leads 3 cancer trials in OnCo, testing the tumour-infiltrating lymphocyte therapies GT101 and GT201 and the CAR-T GT719 in cervical cancer, non-Hodgkin lymphoma and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/grit-bio/>, <https://grit-bio.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://grit-bio.com/>, <https://clinicaltrials.gov/search?lead=Grit%20Biotechnology> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:trials <https://onco.cc/trials/nct06241781/>, <https://onco.cc/trials/nct06948981/>, <https://onco.cc/trials/nct06144671/> .